Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jan 23, 2018
In March 2015, Tom Howing was diagnosed with Stage IV cancer throughout his body. After two rounds of surgery, chemotherapy and some promising early results, the cancer returned. Doctors recommended Tom join a Phase 1 clinical trial sponsored by Forty Seven, Inc., which uses a combination approach to help a patient’s own immune system fight and kill cancer cells. Phase 1 clinical trials are used to determine safety of the treatment and there are still many “unknowns.” Even so, Tom’s scans and blood tests showed the cancer appeared to be held in check—and that was a win. “I’m doing surprisingly well,” he said. “The treatment is so much less aggressive than chemo.”